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Abstract
Background: Ambulatory geriatric rehabilitation (AGR) is a community based outpatient intervention which aims
to improve physical function, maintain independent living of geriatric patients, avoiding hospitalisation and
institutionalisation. It should therefore reduce health care costs. The objective of our study is to evaluate the
effectiveness of AGR for frail elderly patients insured by the statutory health insurance AOK Nordost compared to
care as usual. Outcome variables are progression to higher nursing care levels, admission to nursing home,
incident fractures, hospital admission, ambulatory care sensitive hospital admissions, days spent in hospital, and
health care costs.
Methods: This matched cohort study aims to estimate average treatment effects of AGR. For this purpose we will
compare patients receiving AGR with matched patients receiving care as usual. Patients in the intervention group were
treated between the years 2009 and 2013 from three centres in Mecklenburg-Vorpommern, Germany. Matching will be
conducted using propensity score techniques. Claims data will be provided by the statutory health insurance AOK
Nordost. The primary outcomes are the progression of nursing care levels, incident fractures, and admission to nursing
home. Secondary outcomes are total and ambulatory care sensitive hospital admissions, and health care costs from the
statutory health insurance perspective. Data will be analysed using appropriate regression models.
Discussion: This study aims to quantify the effectiveness of AGR. Results will be important for providers of AGR, policy
makers and stakeholders to make informed decisions on whether to continue, modify or extend AGR.
Trial registration: German Clinical Trials Register (DRKS) S00008926, registered 29.07.2015
Keywords: Ambulatory geriatric rehabilitation, Geriatric multimorbidity, Health claims data, Matched cohort study,
Propensity score matching
Background
Many elderly will experience a reduction in physical func-
tion, leading to more falls and injuries. This leads to a loss
of independence, hospitalisation, long-term nursing home
care as well as premature death [1, 2]. In 2013, 2.63 mil-
lion people in Germany were in need of nursing care.
Roughly two third of them received ambulatory nursing
care and one third received care in a nursing home. From
the years 2011 to 2013, people receiving nursing care in-
creased by 5% [3]. In 2014, 27% of the population aged
65–79 received either ambulatory or institutionalised
nursing care [4]. Given the projected demographic
changes in Germany, the population in the age group
≥65 years will increase from 21% (17.3 million) in the year
2015 to 27% (21.8 million) in the year 2030 [5]. Long term
nursing care and institutionalisation in a nursing home
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can be associated with a significant reduction of quality of
life, mainly due to loss of autonomy and social contacts
[6]. The increased need of long term nursing care poses a
major economic challenge [7]. Thus measures to prevent,
minimise or delay long term nursing care for elderly are
urgently needed.
Germany has mandatory nursing care insurance at-
tached to statutory health insurance since 1995. Elderly
with disabilities or dementia can apply for a nursing care
level [Pflegestufe]. To identify elderly in need, a basic
geriatric assessment performed in general practice was
introduced in 2005 [8]. Although elderly are entitled to
rehabilitative services as codified in the Book V (SGB V)
and XI (SGB XI) of the German social code general
practitioners have only limited access to specialised re-
habilitative services for geriatric patients. While the
number of hospitals providing geriatric services is in-
creasing, the demand for ambulatory services is not met
[9]. Elderly patients with a need for rehabilitation prefer
to stay close to their home and relatives, maintaining
their everyday life [10]. Consequently, ambulatory re-
habilitation is preferred. Rehabilitative services were and
are still mainly available after hospitalisation e.g. for
stroke or fracture after a fall.
Preventive ambulatory geriatric rehabilitation (AGR
[Ambulante Geriatrische Komplexbehandlung]) was in-
troduced in 2008 within the legal frame (§ 140 Book V
of the social code) of selective contracts for integrated
care. Therefore it is only available as a model interven-
tion in some areas for holders of specific statutory health
insurances (e.g. AOK Nordost). AGR is not part of regu-
lar health care.
It is intended as a community based outpatient inter-
vention to improve patient’s physical function, increase
patient’s safety and quality of life as well as to prevent
falls and injuries, to avoid and delay hospitalisation, the
progression of nursing care level and admission to nurs-
ing home.
A systematic review of controlled trials of ambulatory
and hospital interventions to improve physical function
and maintain independent living in elderly people con-
cluded that they were effective to achieve the goal [1]. This
review comprised only one German trial which included
geriatric patient post hospital discharge [11]. However,
AGR is primarily intended to prevent hospitalisation and
not as a post-discharge rehabilitation. The effectiveness of
German AGR programs has not been evaluated rigorously
yet. Previous studies have relied on uncontrolled study de-
signs [12].
Objectives and hypotheses
The aim of our study is to evaluate the effectiveness of
AGR regarding patient’s progression to higher nursing
care levels, incident fractures, admission to nursing home,
hospital admissions as well as health care costs. For this
purpose we compare patients receiving AGR with patients
receiving care as usual. We will estimate average treat-
ment effects based on a cohort design using propensity
score techniques to match cases and controls. The follow-
up period will be up to 2 years.
Our primary hypotheses are:
1. AGR reduces and delays progression to higher
nursing care levels.
2. AGR reduces and delays nursing home admissions.
3. AGR reduces the risk of incident fractures.
Our secondary hypotheses are:
1. AGR decreases and delays hospital admissions and
reduces the days spent in hospital during follow-up
time.
2. AGR decreases and delays ambulatory care sensitive
hospital admissions.
3. AGR decreases total health care costs from the
statutory health insurance perspective.




The conduct of a randomised controlled trial to
assess the effectiveness of AGR is currently limited
due to logistic and ethical reasons. Therefore we will
conduct a matched cohort study using claims data.
Anonymised data will be provided by the statutory
health insurance AOK Nordost which comprises basic
demographic data, data on nursing care level, admis-
sion to a nursing home, billing data for ambulatory
services (EBM position numbers) and for hospital ser-
vices (DRG-codes/OPS-codes), as well as diagnoses
(ICD-10 codes), and all health care costs, including
costs for hospitalisation, remedies and aids, ambula-
tory costs and costs for medication. To balance po-
tential confounders, we will apply a propensity score
matching. Controls will be matched patients insured
by the AOK Nordost.
The observation period comprises 4 billing periods
(each 3 months, corresponding to 1 year) prior to the
intervention, the intervention (index) billing period,
and up to 8 billing periods post intervention, result-
ing in a total observation period of up to 13 billing
periods. The billing period covering the most days of
the intervention will be considered as the index
billing period. Participants in the intervention group
received a 4 weeks AGR in between the years 2009
and 2013.
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Description of the AGR intervention and the setting
AGR is a multimodal intervention consisting of physiother-
apy, ergotherapy, speech therapy, occupational therapy,
social support by qualified social workers, psychological
counselling and counselling regarding aids and care. Pa-
tients who are deemed suitable for AGR by their general
practitioners can be referred to special rehabilitation centre
for a geriatric assessment. If they fulfil eligibility criteria for
AGR and agree to participate they receive the intervention.
The intervention is tailored to the patients’ needs and
delivered in individual and group sessions. Patients are
commonly treated for a total of 20 days with two to three
30 min therapy units per day. Included are meals and a
pick up and return service for the elderly every day. Dur-
ing the intervention period AGR was available in three
locations in Mecklenburg-Vorpommern (Trassenheide,
Ueckermünde, Waren) (Fig. 1).
Eligibility criteria for AGR
Due to selective contracts only patients insured by the
AOK Nordost are entitled to receive AGR. The geriatric
assessment comprises the activity of daily living scale
(Barthel-Index), instrumental activity of daily living,
Timed “Up & Go”, Chair-Rising-Test, Tandem Stance,
Berg-Balance-Scale, and handgrip strength. Eligibility
criteria are:
1. Aged 70 and older
2. at least two geriatric multimorbidity listed in Table 1
3. impairment or handicap with functional deficits
4. at least one of the health conditions listed in Table 2
Patients are not eligible for AGR if the assessment in-
dicates a need for hospital admission, if they are not able
to participate due to a poor health status or if they are
unable to provide informed consent.
Exclusion criteria from the analyses
We aim to quantify treatment effects for typical AGR pa-
tients. Therefore, we will exclude participants with rare
conditions which are likely to affect the health course be-
yond the effects which can be reasonably assumed from
AGR (e.g. organ transplantation, dialysis, chemotherapy) or
participants with extremely high health care costs indicat-
ing severe conditions. Prespecified criteria used to exclude
AGR participants from our analyses are shown in Table 3.
Exclusion criteria for AGR participants also apply to poten-
tial controls.
Sample size
The intervention group consists of all AGR participants,
receiving the AGR in Mecklenburg-Vorpommern during
the years 2009–2013. This will comprise approximately
700 patients. Controls will be chosen from a pool of
around 250.000 members of the AOK Nordost aged
70 years and older. Approximately 2800 controls will be
selected from the pool.
Fig. 1 Map of Mecklenburg-Vorpommern with the three locations which provided AGR
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Outcome measures and data collection
Claims data will comprise the billing periods from
01.01.2008 until 31.12.2014, thus ensuring a minimal ob-
servation period of 12 months prior and after the index
billing period. All variables are provided for each billing
period during the observation period.
The primary outcomes are ‘progression of nursing care
level’, ‘admission to nursing home’ and ‘incident fractures’.
Four nursing care levels (0–3) are defined by the German
social code XI (SGB XI). The nursing care level needs to
be approved by the Medical Review Board of the statutory
health insurances (MDK) in a standardised procedure. The
definition for nursing care level is described in Table 4
[13]. Elderly who do not reach the requirements for nurs-
ing care level I, but need help for daily living (SGB XI §
45a) receive care for their needs. This is referred to as
nursing care level 0 [13].
The outcomes ‘admission to nursing home’ and ‘inci-
dent fractures’ are both coded as binary variables, stating
whether the patients experienced the event after the
index billing period or not.
Secondary outcome variables are ‘any hospital admis-
sion’ (yes/no), ‘days spent in the hospital’, ‘ambulatory
care sensitive hospital admissions’ (yes/no) and ‘total
health care costs from the statutory health insurance per-
spective’ during the entire follow-up period and during
each billing period in the follow-up period. Ambulatory
care sensitive hospital admissions are defined as poten-
tially preventable hospital admissions by interventions in
primary care and are displayed in Table 5. Conditions
were chosen from two studies [14, 15].
Table 1 Geriatric multimorbidity
Criteria ICD-10 codes
Immobility M96.8, M62.3, M62.5
cognitive impairment G30, F00 – F07
incontinence R32, N39, R15
decubitus ulcer L89, L97, I83, L98
Malnutrition R64, E41, E43, E44
Disturbances in fluid and
electrolyte balance
E86, E87, R60
Depression and Anxiety F30 – F33, F40, F41
chronic pain R52
paraesthesia R20, G50 – G59, G60 – G64
frailty R54
severe visual or hearing
impairment
H25, H28, H52-H54, H90, H91
Table 2 Eligibility criteria for participation in AGR
Eligibility criteria ICD-10 codes
Stroke and other cerebrovascular disorders I60-I69
Status post fracture S72.-
Arterial obstructive disease with amputation
or other surgery
I70.-




Exacerbated chronic obstructive pulmonary
disease
J44.0, J44.1
Pneumonia and other respiratory tract
infections
J10-J22
Other fractures and injuries S00-T98
Other arthropathies M00-M25
Spondylopathies and Discopathies, possibly
with laminectomy
M45-M51
Coronary heart disease and other heart
diseases with cardiac surgery
I05-I09; I20-I25
Delirium and other organic brain psychosis F00-F05
Osteoporosis M80-M81
Secondary Parkinsonsyndrom G20.9
Symptoms, effecting the nervous system
and musculoskeletal system
R29.5, R29.6, R29.8
Table 3 Criteria for the exclusion of AGR participants for study
analysis
Exclusion criteria
- Age <70 or >95 years in the intervention billing period
Prior to the intervention billing period:
- nursing care >2
- <360 insured days in the four previous billing periods
- living in a nursing home
- hospital costs without out of pocket spending at the last billing
period >33.000 €
- hospital costs without out of pocket spending during the four last
billing periods ≥44.000 €
- ambulatory costs during the last billing period ≥2.200 €
- ambulatory costs during the four last billing periods ∑ ≥5.500€
- remedy costs without out of pocket spending during the four previous
billing periods ≥2.200 €
- costs of aid without out of pocket spending during the four previous
billing periods ≥4.000 €
- drug costs without out of pocket spending during the four previous
billing periods AGR ≥11.000 €
- total health care costs without out of pocket spending during the four
previous billing periods ≥44.000 €
- diagnosed AIDS/HIV in the four previous billing periods
- chemotherapy in the four previous billing periods
- organ transplantation during the four previous billing periods
- dialysis during the four previous billing periods








in total daily help)
1 minimum 1,5 h >45 min
2 minimum 3 h ≥2 h, 3 times a day
3 minimum 5 h ≥4 h permanent help
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‘Total health care costs’ comprises expenditures for
hospitalisation, remedies and medical aids, ambulatory
costs, and medication. The variables concerning costs
refer to costs excluding out-of-pocket spending except
for remedies and medical aids where the available data
Table 5 Ambulatory care sensitive conditions used to define





Ischaemic heart diseases I25.0, I25.1, I25.5, I25.6, I25.8, I25.9
Heart failure I50
Other diseases of the circulatory
system
I05, I06, I08.0, I49.8, I49.9, I67.2, I67.4,
I70, I73, I78, I80.0, I80.80, I83, I86, I87,
I95, R00.0, R00.2
Bronchitis & COPD J20, J21, J40-J44, J47
Mental and behavioural disorders
due to use of alcohol or opioids
F10, F11
Back pain [dorsopathies] M42, M47, M53, M54
Hypertension I10 - I15
Gastroenteritis and other diseases
of intestines
K52.2, K52.8, K52.9, K57, K58, K59.0
Intestinal infectious diseases A01, A02, A04, A05, A07-A09
Influenza and pneumonia J10, J11, J13, J14, J15.3, J15.4, J15.7,
J15.8, J15.9, J16.8, J18.0, J18.1, J18.8,
J18.9
Ear nose throat infections H66, H67, J01-J04, J06, J31, J32, J35
Depressive disorders F32, F33
Diabetes mellitus E10.2-E10.6, E10.8, E10.9, E11, E13.6,
E13.7, E13.9, E14, E16.2
Gonarthrosis [arthrosis of knee] M17.0, M17.1, M17.4, M17.5, M17.9
Soft tissue disorders G56.0, M67.4, M71.3, M75-M77, M79
Other avoidable mental and
behavioural disorders
F40, F41, F43, F45, F50.0, F50.2, F60
Diseases of the eye H25, H40
Diseases of urinary system N30, N34, N39.0
Sleep disorders G47
Diseases of the skin and
subcutaneous tissue
A46, L01, L02, L04, L08.0, L08.8, L08.9,
L60.0, L72.1, L98.0
Thyroid disorder E03 - E05, E89.0
Metabolic disorders E86, E87.6
Melanoma and other malignant
neoplasms of skin
C43, C44
Gastritis and duodenitis K21, K29.7, K29.9, K30, K31
Migraine and headache
syndromes




E40 - 64, R63.6, D50, D51-D52, D53.1,
D56
Alcoholic liver disease K70
Dental diseases K02, K04-K06, K08, K12, K13
Inflammatory diseases of female
pelvic organs and disorders of
female genital tract
N70-N72, N75, N76, N84.1, N86, N87
Dementia F01, F03
Diseases of male genital organs N41, N45, N48.4
Asthma J45
Other polyneuropathies G62
Table 5 Ambulatory care sensitive conditions used to define
hospital admissions to be prevented by AGR (according to
[14, 15]) (Continued)
Avoidable infectious and parasitic
diseases
A15.3, A15.4, A15.9, A16.2, A16.3,
A16.5, A16.8, A16.9, A34 - A37, A50-
A58, A63, A64, A80, B05 - B07, B15,
B16.1, B16.9, B17, B18.0, B18.1, B20 -








Rare diseases with <5000 cases
each
F80, R63.0, R63.3, R63.8, Z73
Cellulitis L03, L04, L08.0, L08.8, L08.9, L88,
L98.0, I891, L010, L011, L020 - L024,
L028, L029
Angina I20, I24.0, I24.8, I24.9, I25, R072, R073,
R074, Z034, Z035
Convulsions and epilepsy G25.3, G40, G41, O15, R56, R568
Dehydration and infections A02, A04, A09, A05.9, A07.2, A08.0,
A08.1, A08.3, A08.4, A08.5, E86, K52.0,
K52.1, K52.2, K52.8, K52.9
Gangrene R02
Iron-deficiency anaemia D46.0, D46.1, D46.3, D46.4, D50.1,
D50.8, D50.9, D51.0–D51.3, D51.8,
D52.0, D52.1, D52.8, D52.9, D53.1,
D57.1, D58.0, D58.1, D59.0 – D59.2,
D59.9, D60.1, D60.8, D60.9, D61.0,
D61.1, D64.0 - D64.4, D64.8
Pelvic inflammatory disease N70, N73, N74
Perforated/bleeding ulcer K20, K21.0, K21.9, K22.1, K22.6, K25.0
– K25.2, K25.4 – K25.6, K25.9, K26.0 –
K26.2, K26.4 – K26.6, K27,K28.0 – 28.2,
K28.4 – K28.6, K92.0, K92.1, K92.2, L97
Pyelonephritis N10, N11, N12, N13.6, N15.9, N30.0,
N30.8, N30.9, N39.0,








Neuroses E10, E13.6 – E13.9, E14.9
Tuberculosis A15, A16, A17, A18, A19
Schizophrenia F20, F21, F23.2, F25
Stroke I61, I62, I63, I64, I66, I67.2, I69.8, R47.0
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does not allow for any separate analysis of out-of-pocket
spending.
Matching and statistical analyses
To balance the distribution of potential confounders
among cases and controls we will conduct a propensity
score matching using a many-to-one matching [16]. Var-
iables for the estimation of the propensity score will be
selected based on their expected importance to predict
AGR participation as well as the outcomes of interest.
We will perform a two-step matching process. In the
first step, for all patients who received AGR in a deter-
mined billing period, we plan to match controls with
similar morbidity and cost characteristics during a.) the
four billing periods prior to the index period in which
the intervention took place, and b.) by additionally in-
cluding the index period in the matching. This first step
allows for the definition of an index period in controls.
Using variables during the index billing period is compli-
cated by the fact that no information on the temporal
sequence of events within a billing period is available
due to legally obliged data protection agreements. How-
ever, ignoring the index period may lead to a systematic
ignorance of events leading to AGR which might have
taken place in the index period. Therefore results from
both analysis scenarios (a., b.) will be systematically
compared. The first-step will be conducted as an exact
match (pre matching) on selected variables listed in
Table 6. These variables were selected due to their high
expected conceptual importance for the estimation of
treatment effects. Should no adequate numbers of
controls be found, a more lenient matching may be









Area of residence x
Days being insured x
Level of nursing care x x
Hospital admission yes/no x x
Charlson Comorbidity index (CCI) x
Days spent in the hospital x
Hospital costs without out-of-pocket spending x x
Ambulatory costs x
Costs of remedy x
Costs of medical aid x
Drug costs without out-of-pocket spending x x
Total costs with out-of-pocket spending x
Main diagnoses before AGR
Musculo-skeletal x a
Status post fracture or joint replacement
Cox- or gonarthrosis with endoprothesis x







Pneumonia and other lung inflammations x a x
Cardio-vascular system
Heart failure
Chronic obstructive pulmonary disease
(COPD)
x
Arterial obstructive disease with
amputation or other surgery
x a x
Coronary heart diseases with surgery x




Delirium and other organic brain psychosis x
Secondary Parkinsonsyndrom x a x




Any Malignancy x x
Cerebrovascular disease x
Chronic pulmonary disease x
Congestive heart failure x
Metastatic solid tumor x
Table 6 Matching criteria (Continued)
Dementia x x
Hemiplegia or paraplegia x
Mild liver disease x
Myocardial infarction x
Renal disease x










aAt least one diagnosis from each main diagnosis group will be used to match
controls. Diagnoses are allowed to differ between cases and controls within
the main diagnoses group
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employed. Controls will be drawn with repetition across
billing periods. We plan to match up to 100 controls per
case at this stage.
Subsequently, propensity scores will be calculated using
a logistic regression model using coded morbidity and
costs under the scenarios a.) and b.), based on all variables
listed in Table 6, taking statistical interactions and nonlin-
ear associations into account. Up to four controls may be
assigned to one case without repetition.
Appropriate regression models (e.g. time-event models,
mixed models, two-part models) will be applied to study
effects on our primary and secondary outcomes. Because
treatment might also affect censoring due to mortality,
competing risks models (using the Fine-Gray approach)
will be applied [17]. Patients dying during the follow-up
period will not be excluded from the analyses.
Discussion
AGR is currently only available in few areas for elderly
people from selected statutory health insurances which
opted to offer AGR to their beneficiaries. Evaluation of this
intervention was previously limited to uncontrolled study
designs [12]. To the best of our knowledge, this will be the
first study to evaluate AGR using a quasi-experimental de-
sign. This study may provide an estimation of the effective-
ness of AGR on progression to higher nursing care levels
and hospitalisation and other endpoints of clinical rele-
vance. Our results will be important for providers of AGR,
policy makers and stakeholders to make informed decisions
on whether to continue, modify or even expand AGR to
other areas in Germany. Additionally, our results might
help to optimise AGR by identifying subgroups of patients
who are more likely to benefit from AGR.
A limitation will be the restriction to claims data. Clin-
ical measurements from instruments used for the geriatric
assessment are not available for the control group. This
might impair the quality of the matching as potential im-
balance between clinical data and individual motivation to
participate in AGR cannot be ruled out even if a high bal-
ance on claims data is achieved. Therefore, residual con-
founding may still be an issue after our matching. Final
decisions on the applied methods need to account for the
precise properties of the data.
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